Robinhood Chain TVL surpasses $10M as Lighter integration gains traction
Robinhood just launched a blockchain, and people are actually using it. Lighter, the zero-knowledge rollup decentralized exchange serving as Robinhood Chain’s default perpetual futures platform, has crossed $10 million in total value locked on the network. The broader Robinhood Chain itself tells an even more striking story. The network’s DeFi TVL climbed past $50 million within days of going live, then crossed the $100 million mark in under a week.
What Robinhood Chain actually is
Robinhood Chain launched mainnet on July 1-2, 2026, built on the Arbitrum network as an Ethereum Layer-2. The chain is designed to connect Robinhood’s existing user base directly to on-chain DeFi infrastructure, with Robinhood Wallet as the primary access point.
Lighter serves as the chain’s default decentralized exchange, specifically for perpetual futures trading. Users can deploy Robinhood Chain assets, including the USDG stablecoin, to trade perps through Lighter without leaving the Robinhood Wallet environment. This deployment is what Lighter calls its first “Lighter Domain,” meaning a chain-specific deployment tailored to a particular ecosystem.
Lighter committed roughly $11 million worth of its native LIT token as trading incentives specifically for Robinhood users. On top of that, trades conducted through the Robinhood Wallet earn a 2x points bonus.
LIT token and the funding backstory
Lighter raised $68 million in November 2025, with Robinhood itself listed among the backers. Lighter’s CEO Vladimir Novakovski has positioned the Robinhood Domain deployment as a foundation for broader distribution going forward.
The LIT token responded to the launch announcement with price gains ranging between 15% and 80%, depending on the timeframe measured. Reports tied the momentum to a combination of integration excitement, token buyback mechanisms, and burn updates.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Weight-loss drug receives FDA warning for rare eye disease; Novo Nordisk (NVO.US) and Eli Lilly (LLY.US): No evidence of causality
The FDA requires all GLP-1 drugs to include a warning about the rare eye disease NAION. Novo Nordisk and Eli Lilly deny any causality, while Citi states that the impact on adoption is limited.
Anthropic Roadshow PPT: "Computing Power" Mentioned 49 Times, "Safety" 27 Times; Revenue Grows 12 Times in a Year, Long-term Profit Margin Target at 35%
In Anthropic's IPO roadshow video, "computing power" was mentioned 49 times, and "security"-related terms were mentioned 27 times; the CEO mentioned the risk of biological weapons within about 30 seconds of the opening speech. The PPT shows that third-quarter revenue was $16.956 billion, a year-on-year increase of over 12 times, adjusted operating profit margin was 15% (GAAP: -3%), computing power commitments were about $900.9 billion, and the long-term profit margin target is above 35%.
Crypto prices
More
